AGARWALEYE
Dr. Agarwal's Health Care Limited operates eye hospitals in India and internationally. It offers cataract surgeries, such as small incision cataract surgery, phacoemulsification, robotic cataract surgery, and glued intraocular lens treatments; and refractive surgeries, including surgical procedures to correct the refractive error of the eye to get rid of or reduce dependence on glasses and contac… Read more
AGARWALEYE (AGARWALEYE) - Total Assets
Latest total assets as of September 2025: ₹37.86 Billion INR
Based on the latest financial reports, AGARWALEYE (AGARWALEYE) holds total assets worth ₹37.86 Billion INR as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
AGARWALEYE - Total Assets Trend (2021–2025)
This chart illustrates how AGARWALEYE’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
AGARWALEYE - Asset Composition Analysis
Current Asset Composition (March 2025)
AGARWALEYE's total assets of ₹37.86 Billion consist of 21.6% current assets and 78.4% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₹0.00 | 7.0% |
| Accounts Receivable | ₹1.24 Billion | 3.4% |
| Inventory | ₹802.70 Million | 2.2% |
| Property, Plant & Equipment | ₹0.00 | 0.0% |
| Intangible Assets | ₹4.57 Billion | 12.5% |
| Goodwill | ₹7.35 Billion | 20.0% |
Asset Composition Trend (2021–2025)
This chart illustrates how AGARWALEYE's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: AGARWALEYE's current assets represent 21.6% of total assets in 2025, an increase from 19.6% in 2021.
- Cash Position: Cash and equivalents constituted 7.0% of total assets in 2025, up from 7.0% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 32.0% of total assets, an increase from 14.0% in 2021.
- Asset Diversification: The largest asset category is goodwill at 20.0% of total assets.
AGARWALEYE Competitors by Total Assets
Key competitors of AGARWALEYE based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Beijing Centergate Technologies Holding Co Ltd
SHE:000931
|
China | CN¥3.82 Billion |
|
Blue Sail Medical Co Ltd
SHE:002382
|
China | CN¥16.46 Billion |
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥28.98 Billion |
|
Allmed Medical Products Co Ltd Class A
SHE:002950
|
China | CN¥5.35 Billion |
|
Inix Technologies Holdings Bhd
KLSE:0094
|
Malaysia | RM72.53 Million |
|
Focus Point Holdings Bhd
KLSE:0157
|
Malaysia | RM328.19 Million |
|
Careplus Group Bhd
KLSE:0163
|
Malaysia | RM286.61 Million |
|
LKL International Bhd
KLSE:0182
|
Malaysia | RM173.46 Million |
AGARWALEYE - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - AGARWALEYE generates 0.47x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, AGARWALEYE generates $ 2.27 in net profit.
AGARWALEYE - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.43 | 1.62 | 1.85 |
| Quick Ratio | 1.26 | 1.47 | 1.71 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ₹1.97 Billion | ₹ 2.76 Billion | ₹ 3.52 Billion |
AGARWALEYE - Advanced Valuation Insights
This section examines the relationship between AGARWALEYE's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 7.37 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | 31.9% |
| Total Assets | ₹36.72 Billion |
| Market Capitalization | $295.11 Million USD |
Valuation Analysis
Below Book Valuation: The market values AGARWALEYE's assets below their book value (0.01 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: AGARWALEYE's assets grew by 31.9% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for AGARWALEYE (2021–2025)
The table below shows the annual total assets of AGARWALEYE from 2021 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | ₹36.72 Billion | +31.95% |
| 2024-03-31 | ₹27.83 Billion | +52.46% |
| 2023-03-31 | ₹18.25 Billion | +77.87% |
| 2022-03-31 | ₹10.26 Billion | +30.39% |
| 2021-03-31 | ₹7.87 Billion | -- |